Dr Agarwals Health Care is a trusted eye care organization established in Chennai in 2010 by Dr T.S. Agarwal. It started as a small eye hospital but has become one of India’s leading providers of advanced eye care; it offers various services, including cataract surgeries, LASIK treatments, retinal treatments, corneal care and pediatric eye care.
This blog will provide the details of Dr Agarwals Health Care Share Price targets as far as 25 years from now (2025 – 2050) based on its fundamentals, market position, and growth potential.
What is Dr Agarwals Health Care Ltd NSE: AGARWALEYE?
In 2010, Dr Agarwals Health Care Ltd. started in Chennai, where it is now its headquarters. Dr Agarwal’s Health Care offers affordable optical products such as eyeglasses and contact lenses. It uses state-of-the-art laser systems, modern imaging techniques, and tools to provide world-class treatment. In more than 150 centres worldwide, they help people in India, Africa and Southeast Asia to see better and live healthier lives.
Dr Agarwals Health Care Share Price Target Tomorrow
Dr Agarwals Health Care Ltd. has an estimated market capitalization of Rs12,698 crore with an impressive P/E ratio of 153 and ROCE of 23.3%, indicating high efficiency. In FY24, the company reported a net profit of Rs95 crore and quarterly revenue growth of over 26.05%. These factors could positively impact the share price. Still, investors need to monitor market trends to make informed decisions.
NOTE! Signals may differ across timeframes. If you’re planning to purchase AGARWALEYE and keep it for more than one week, it’s suggested that you choose signals from weekly and daily timeframes. For trading in the short term, signals that range from 5 minutes to 1-hour timeframes are better appropriate.
Dr. Agarwals Health Care is expanding steadily and has 193 facilities in 117 cities across India. The rapid expansion is due to the high quality of services, advanced surgeries, and excellent reputation in ophthalmology, which they are proud of. Their commitment to pulse surgeries guarantees patient satisfaction. In addition, experienced doctors in all 193 facilities across India ensure long-term financial performance, underpinned by increasing revenues from surgical procedures performed, giving investors confidence in long-term investment success! Our analysis shows that the share price is expected to be between Rs 382 and Rs 480.
Year
Minimum Price (₹)
Maximum Price (₹)
2025
325
550
Month
Minimum Price (₹)
Maximum Price (₹)
February
330
460
March
340
470
April
350
480
May
360
490
June
370
500
July
380
510
August
390
520
September
400
530
October
410
540
November
420
545
December
430
550
Dr Agarwals Health Care Share Price Target 2026
Dr. Agarwals Health Care is expected to expand further in 2026 and reach out to underserved areas and smaller cities by providing quality eye care services at reasonable costs. As the demand for eye care services increases, their growing medical centres will help meet the demand. Modern technologies, such as robotic cataract surgery, will improve patient care. Their flexible business model allows them to respond quickly to market conditions and ensure continued international growth as satisfied patients and expanding market share drive their success. Our analysis shows that the share price is expected to be between Rs 490 and Rs 680.
Year
Minimum Price (₹)
Maximum Price (₹)
2026
490
680
Month
Minimum Price (₹)
Maximum Price (₹)
January
490
540
February
500
550
March
510
560
April
520
570
May
530
580
June
540
590
July
550
600
August
560
620
September
570
630
October
580
640
November
590
660
December
600
680
Dr Agarwals Health Care Share Price Target 2030
By 2030, Dr. Agarwals Health Care is expected to expand its global footprint further and penetrate emerging markets such as Africa. With state-of-the-art ophthalmology and advanced surgeries, Dr Agarwal’s will remain a leader in the industry; its reputation for quality services will ensure high patient retention; with new surgical treatments, training programs and centres of excellence, Dr Agarwal’s will maintain its leadership position and ensure long-term financial success and high returns for investors. Our analysis shows that the share price is expected to be between Rs 1330 and Rs 1735.
Year
Minimum Price (₹)
Maximum Price (₹)
2030
1,320
1,735
Month
Minimum Price (₹)
Maximum Price (₹)
January
1,320
1,390
February
1,335
1,405
March
1,350
1,420
April
1,365
1,450
May
1,380
1,470
June
1,400
1,490
July
1,420
1,510
August
1,440
1,540
September
1,460
1,580
October
1,480
1,600
November
1,500
1,660
December
1,520
1,735
Dr Agarwals Health Care Share Price Target 2040
In 2040, with its growing network of centres and expanding infrastructure, Dr Agarwals Health Care will continue to be a leader in global ophthalmology, developing patient care while meeting the ever-increasing demand for ophthalmology domestically and internationally. Dr Agarwals will continue to invest in technology and skilled physicians to meet the increasing demand for eye care worldwide – this commitment to patient satisfaction and expansion of services will ensure the long-term growth and success of the company. Our analysis shows that the share price is expected to be between Rs 2715 and Rs 3370.
Year
Minimum Price (₹)
Maximum Price (₹)
2040
2,715
3,370
Month
Minimum Price (₹)
Maximum Price (₹)
January
2,715
2,820
February
2,735
2,850
March
2,760
2,890
April
2,780
2,920
May
2,800
2,950
June
2,820
2,980
July
2,840
3,010
August
2,860
3,040
September
2,880
3,070
October
2,900
3,100
November
2,920
3,150
December
2,940
3,370
Dr Agarwals Health Care Share Price Target 2050
By 2050, Dr. Agarwals Health Care will have established itself as an international brand with facilities in developed and emerging markets. With advanced technologies such as robotic cataract surgery, Dr. Agarwal’s Health Care will continue to be a leader in ophthalmology. With an expanding network and an excellent reputation, Dr Agarwal’s Health Care will remain a trusted name in ophthalmology – investors will benefit from long-term growth as they see the company continue to increase revenue and satisfy patients worldwide. Our analysis shows that the share price is expected to be between Rs 5200 and Rs 6100.
Dr Agarwals Health Care Ltd. is expanding rapidly with 193 centres in 117 cities, offering advanced eye care by experienced doctors. In addition, the company’s footprint is quickly growing to smaller cities and emerging markets in Africa, offering investors a solid return on investment. Given the company’s growth potential and reputation, buying shares could be a rewarding investment opportunity.
Dr Agarwals Health Care Ltd Earning Results (Financials)
Particulars
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Sales
₹1,332 Crore
₹1,018 Crore
₹696 Crore
₹471 Crore
₹531 Crore
Expenses
₹970 Crore
₹745 Crore
₹511 Crore
₹387 Crore
₹407 Crore
Operating Profit
₹362 Crore
₹273 Crore
₹186 Crore
₹85 Crore
₹124 Crore
Operating Profit Margin (OPM)
27%
27%
27%
18%
23%
Other Income
₹44 Crore
₹15 Crore
₹18 Crore
₹6 Crore
₹13 Crore
Interest
₹96 Crore
₹76 Crore
₹49 Crore
₹44 Crore
₹54 Crore
Depreciation
₹170 Crore
₹128 Crore
₹98 Crore
₹95 Crore
₹93 Crore
Profit Before Tax
₹141 Crore
₹84 Crore
₹57 Crore
₹-48 Crore
₹-11 Crore
Tax %
32%
-23%
24%
21%
82%
Net Profit
₹95 Crore
₹103 Crore
₹43 Crore
₹-59 Crore
₹-21 Crore
Expert Forecasts On The Future Of Dr Agarwals Health Care Ltd.
Experts believe Dr Agarwals Health Care Ltd. has significant growth potential with a market capitalization of Rs. 12,698 crores, an impressive ROCE of 23.3% and a steady net profit of Rs. 95 crores. Although the P/E ratio is 153, the ROCE of 23.3% and the steady net profit of Rs 95 crores show the company’s stability as an solid financial health. The experts anticipate further expansion through debt management techniques and operational efficiencies while watching for changes that could impact dividend payouts to maximize long-term returns in their portfolios.
Is Dr Agarwals Health Care Stock Good to Buy? (Bull case & Bear case)
Bullish Case:
Strong market capitalization of ₹12,698 Cr.
High ROCE of 23.3% and steady profits.
Expanding network with over 193 facilities.
Strong growth in the Indian ophthalmology market.
Bearish Case:
High P/E ratio of 153, which could indicate overvaluation.
No dividend payout last year.
Debt level of ₹1,034 Cr. needs to be monitored carefully.
Dr Agarwals Health Care Ltd. has tremendous growth potential with expanding services, high-quality eye care and a significant market share. Although the valuation and debt are high, the company performs exceptionally well financially; investors should closely monitor future growth, debt and market development before deciding.
FAQs
Dr. Agarwal’s Healthcare is known for providing healthcare services in hospitals, clinics and specialty care.
The stock is currently highly valued but has a strong market position, which makes it an attractive option for long-term investors.
The stock has a P/E ratio of 153, which is high compared to the industry average.
The market capitalization is ₹12,698 crore, which indicates a medium to large market capitalization.
No, no dividends were paid last year as per the latest data.
I specialize in stock price predictions and analysis on Share Price Target, offering accurate share price targets for upcoming years. My goal is to provide investors with valuable insights and forecasts to help them make informed decisions in the share market.
